Search for content, post, videos

Spago Nanomedical receives extended patent protection in USA

US patent
Spago Nanomedical has received notice from the United States Patent and Trademark Office (USPTO) that it intends to grant the company’s patent application including a critical component of the SpagoPix candidate drug SN132D. The patent will be granted following confirmation of Spago Nanomedical
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.